Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice
- PMID: 32830899
- DOI: 10.1111/jon.12774
Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice
Abstract
Background and purpose: Meningeal inflammation is implicated in cortical demyelination and disability progression in multiple sclerosis (MS). Gadolinium (Gd)-enhanced 3-dimensional (3D) FLAIR (fluid-attenuated inversion recovery) magnetic resonance imaging (MRI) can identify leptomeningeal enhancement (LME) in MS. Further characterization is needed to determine if LME is an imaging biomarker for meningeal inflammation. We sought to characterize the natural history of LME in the community setting, including persistence/resolution, effect of disease-modifying therapy, scanner variability, timing of acquisition, and imaging pitfalls that may lead to misinterpretation.
Methods: A total of 341 MRI exams with Gd-enhanced 3D-FLAIR were reviewed in MS and non-MS patients to determine frequency of enhancement by MS subtype and association with therapy. A phantom was used to assess scanner variability. Two MS patients with seven LME were imaged at four postinjection time points to generate time-intensity curves. Imaging pitfalls were compiled.
Results: A total of 16.6% (40/241) of MS patients revealed LME compared to 8% (8/100) in non-MS patients (P = .04). There was no association with MS subtype, therapy, or disease activity. Detection using General Electric's version of 3D-FLAIR (29%) was greater than with Siemen's 3D-FLAIR (12%) at 1.5T (Tesla) (P < .001). Lesions were generally stable but resolved in 2 patients following high-dose steroids. LME kinetics were heterogeneous, even within patients, without uniform optimal time for acquisition. Enhancement curves exhibited three different variations, similar to the two-compartment model. Imaging pitfalls included enhancements of uncertain biologic significance, cortical veins and anatomic structures, and imaging artifacts.
Conclusions: Awareness of LME characteristics, variability with imaging parameters, and imaging pitfalls will facilitate determining the potential role as an imaging biomarker for meningeal inflammation.
Keywords: 3D-FLAIR; B-lymphocytes; inflammation; leptomeningeal; multiple sclerosis.
© 2020 American Society of Neuroimaging.
Similar articles
-
Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.PLoS One. 2024 May 29;19(5):e0300298. doi: 10.1371/journal.pone.0300298. eCollection 2024. PLoS One. 2024. PMID: 38809920 Free PMC article.
-
Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis.AJNR Am J Neuroradiol. 2018 Apr;39(4):642-647. doi: 10.3174/ajnr.A5541. Epub 2018 Feb 8. AJNR Am J Neuroradiol. 2018. PMID: 29439125 Free PMC article.
-
Highly Sensitive 3-Tesla Real Inversion Recovery MRI Detects Leptomeningeal Contrast Enhancement in Chronic Active Multiple Sclerosis.Invest Radiol. 2024 Mar 1;59(3):243-251. doi: 10.1097/RLI.0000000000001011. Invest Radiol. 2024. PMID: 37493285 Free PMC article.
-
Leptomeningeal enhancement in multiple sclerosis and other neurological diseases: A systematic review and Meta-Analysis.Neuroimage Clin. 2022;33:102939. doi: 10.1016/j.nicl.2022.102939. Epub 2022 Jan 10. Neuroimage Clin. 2022. PMID: 35026625 Free PMC article.
-
Use of Magnetic Resonance Imaging to Visualize Leptomeningeal Inflammation in Patients With Multiple Sclerosis: A Review.JAMA Neurol. 2017 Jan 1;74(1):100-109. doi: 10.1001/jamaneurol.2016.4237. JAMA Neurol. 2017. PMID: 27893883 Review.
Cited by
-
MUSE and PROPELLER DWI for ADC in parasagittal dura: insights from high-resolution and reduced-distortion DWI.Sci Rep. 2025 Mar 3;15(1):7473. doi: 10.1038/s41598-025-91751-0. Sci Rep. 2025. PMID: 40033025 Free PMC article.
-
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation.Front Neurol. 2024 Jun 5;15:1373385. doi: 10.3389/fneur.2024.1373385. eCollection 2024. Front Neurol. 2024. PMID: 38899059 Free PMC article.
-
Meningeal contrast enhancement in multiple sclerosis: assessment of field strength, acquisition delay, and clinical relevance.medRxiv [Preprint]. 2024 Mar 7:2024.03.04.24303491. doi: 10.1101/2024.03.04.24303491. medRxiv. 2024. Update in: PLoS One. 2024 May 29;19(5):e0300298. doi: 10.1371/journal.pone.0300298. PMID: 38496664 Free PMC article. Updated. Preprint.
-
Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making?Ther Adv Neurol Disord. 2024 Feb 7;17:17562864241229325. doi: 10.1177/17562864241229325. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 38332854 Free PMC article. Review.
-
Fluid and Waste Clearance in Central Nervous System Health and Diseases.Neurodegener Dis. 2025 May 7:1-22. doi: 10.1159/000546018. Online ahead of print. Neurodegener Dis. 2025. PMID: 40334649 Free PMC article. Review.
References
-
- Serafini B, Rosicarelli B, Magliozzi R, et al. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004;14:164-74.
-
- Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128:2705-12.
-
- Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006;6:205-17.
-
- Magliozzi R, Howell O, Vora A, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007;130:1089-104.
-
- Howell OW, Reeves CA, Nicholas R, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 2011;134:2755-71.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical